APA (7th ed.) Citation

van Kooten, H. A., Ditters, I. A. M., Hoogeveen-Westerveld, M., Jacobs, E. H., van den Hout, J. M. P., van Doorn, P. A., . . . van der Beek, N. A. M. E. (2022). Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease. Orphanet Journal of Rare Diseases, 17(1), 1. https://doi.org/10.1186/s13023-022-02175-2

Chicago Style (17th ed.) Citation

van Kooten, Harmke A., Imke A. M. Ditters, Marianne Hoogeveen-Westerveld, Edwin H. Jacobs, Johanna M. P. van den Hout, Pieter A. van Doorn, W. W. M. Pim Pijnappel, Ans T. van der Ploeg, and Nadine A. M. E. van der Beek. "Antibodies Against Recombinant Human Alpha-glucosidase Do Not Seem to Affect Clinical Outcome in Childhood Onset Pompe Disease." Orphanet Journal of Rare Diseases 17, no. 1 (2022): 1. https://doi.org/10.1186/s13023-022-02175-2.

MLA (9th ed.) Citation

van Kooten, Harmke A., et al. "Antibodies Against Recombinant Human Alpha-glucosidase Do Not Seem to Affect Clinical Outcome in Childhood Onset Pompe Disease." Orphanet Journal of Rare Diseases, vol. 17, no. 1, 2022, p. 1, https://doi.org/10.1186/s13023-022-02175-2.